T0	Participants 139 177	locally advanced head and neck cancer:
T1	Participants 481 519	locally advanced head and neck cancer.
T2	Participants 594 738	Three hundred eighty-four patients with stage III (6%) and IV (94%) oropharyngeal (59.4%), hypopharyngeal (32.3%), and oral cavity (8.3%) cancer
T3	Participants 1829 1860	limited to oropharyngeal cancer